SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
Uddhav Timilsina(University at Buffalo, State University of New York), Spyridon Stavrou(University of Pennsylvania)
Cited by 66
Related Papers
Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
|PLoS Pathogens|2014|61
MARCH2, a T cell specific factor that restricts HIV-1 infection
|PLoS Pathogens|2024|6
Elucidating the antiviral mechanism of different MARCH factors
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2
SARS-CoV-2 ORF7a Mutation Found in BF.5 and BF.7 Sublineages Impacts Its Functions
|International Journal of Molecular Sciences|2024|2
DDX41 recognizes RNA/DNA retroviral reverse transcripts and is critical for <i>in vivo</i> control of MLV infection
|bioRxiv (Cold Spring Harbor Laboratory)|2018|0